Decellularized human cadaveric dermis provides a safe alternative for primary inguinal hernia repair in contaminated surgical fields

Daniel Albo, Samir S. Awad, David H. Berger, Charles F. Bellows

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Repair options for inguinal hernias in contaminated surgical fields include local tissue repair or mesh repair. The former is associated with higher hernia recurrence rates. The latter generally is avoided because of an unacceptably high infection rate. AlloDerm (Lifecell Corp., Branchburg, NJ) can potentially provide a strong repair resistant to infection. The aim of our study was to evaluate if AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields. Methods: We retrospectively reviewed the medical records of all patients who underwent inguinal hernia repair with AlloDerm from December 2004 to April 2006. Demographics, risk factors, perioperative data, and recurrence rates were evaluated. Results: Twelve patients with contaminated surgical fields underwent inguinal hernia repair with AlloDerm. Serious perioperative complications occurred in only 1 patient. Two patients developed superficial wound infections (treated conservatively). There were no mortalities. No hernia recurrence has been documented with a follow-up period of 3 to 17 months (median, 9 mo). Conclusions: AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields.

Original languageEnglish (US)
JournalAmerican Journal of Surgery
Volume192
Issue number5 SPEC. ISS.
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Inguinal Hernia
Herniorrhaphy
Dermis
Hernia
Recurrence
Wound Infection
Infection
Medical Records
Demography
Alloderm
Mortality

Keywords

  • AlloDerm
  • Cadaveric dermis
  • Contaminated field
  • Decellularized
  • Inguinal hernia

ASJC Scopus subject areas

  • Surgery

Cite this

Decellularized human cadaveric dermis provides a safe alternative for primary inguinal hernia repair in contaminated surgical fields. / Albo, Daniel; Awad, Samir S.; Berger, David H.; Bellows, Charles F.

In: American Journal of Surgery, Vol. 192, No. 5 SPEC. ISS., 01.01.2006.

Research output: Contribution to journalArticle

@article{2ba1f55353fa42b382b1354855464fac,
title = "Decellularized human cadaveric dermis provides a safe alternative for primary inguinal hernia repair in contaminated surgical fields",
abstract = "Background: Repair options for inguinal hernias in contaminated surgical fields include local tissue repair or mesh repair. The former is associated with higher hernia recurrence rates. The latter generally is avoided because of an unacceptably high infection rate. AlloDerm (Lifecell Corp., Branchburg, NJ) can potentially provide a strong repair resistant to infection. The aim of our study was to evaluate if AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields. Methods: We retrospectively reviewed the medical records of all patients who underwent inguinal hernia repair with AlloDerm from December 2004 to April 2006. Demographics, risk factors, perioperative data, and recurrence rates were evaluated. Results: Twelve patients with contaminated surgical fields underwent inguinal hernia repair with AlloDerm. Serious perioperative complications occurred in only 1 patient. Two patients developed superficial wound infections (treated conservatively). There were no mortalities. No hernia recurrence has been documented with a follow-up period of 3 to 17 months (median, 9 mo). Conclusions: AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields.",
keywords = "AlloDerm, Cadaveric dermis, Contaminated field, Decellularized, Inguinal hernia",
author = "Daniel Albo and Awad, {Samir S.} and Berger, {David H.} and Bellows, {Charles F.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.amjsurg.2006.08.029",
language = "English (US)",
volume = "192",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "5 SPEC. ISS.",

}

TY - JOUR

T1 - Decellularized human cadaveric dermis provides a safe alternative for primary inguinal hernia repair in contaminated surgical fields

AU - Albo, Daniel

AU - Awad, Samir S.

AU - Berger, David H.

AU - Bellows, Charles F.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Background: Repair options for inguinal hernias in contaminated surgical fields include local tissue repair or mesh repair. The former is associated with higher hernia recurrence rates. The latter generally is avoided because of an unacceptably high infection rate. AlloDerm (Lifecell Corp., Branchburg, NJ) can potentially provide a strong repair resistant to infection. The aim of our study was to evaluate if AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields. Methods: We retrospectively reviewed the medical records of all patients who underwent inguinal hernia repair with AlloDerm from December 2004 to April 2006. Demographics, risk factors, perioperative data, and recurrence rates were evaluated. Results: Twelve patients with contaminated surgical fields underwent inguinal hernia repair with AlloDerm. Serious perioperative complications occurred in only 1 patient. Two patients developed superficial wound infections (treated conservatively). There were no mortalities. No hernia recurrence has been documented with a follow-up period of 3 to 17 months (median, 9 mo). Conclusions: AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields.

AB - Background: Repair options for inguinal hernias in contaminated surgical fields include local tissue repair or mesh repair. The former is associated with higher hernia recurrence rates. The latter generally is avoided because of an unacceptably high infection rate. AlloDerm (Lifecell Corp., Branchburg, NJ) can potentially provide a strong repair resistant to infection. The aim of our study was to evaluate if AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields. Methods: We retrospectively reviewed the medical records of all patients who underwent inguinal hernia repair with AlloDerm from December 2004 to April 2006. Demographics, risk factors, perioperative data, and recurrence rates were evaluated. Results: Twelve patients with contaminated surgical fields underwent inguinal hernia repair with AlloDerm. Serious perioperative complications occurred in only 1 patient. Two patients developed superficial wound infections (treated conservatively). There were no mortalities. No hernia recurrence has been documented with a follow-up period of 3 to 17 months (median, 9 mo). Conclusions: AlloDerm provides a safe alternative for inguinal hernia repair in contaminated surgical fields.

KW - AlloDerm

KW - Cadaveric dermis

KW - Contaminated field

KW - Decellularized

KW - Inguinal hernia

UR - http://www.scopus.com/inward/record.url?scp=33750352509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750352509&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2006.08.029

DO - 10.1016/j.amjsurg.2006.08.029

M3 - Article

C2 - 17071174

AN - SCOPUS:33750352509

VL - 192

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 5 SPEC. ISS.

ER -